Maso Capital Partners Ltd - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
Maso Capital Partners Ltd ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q4 2020$1,663,000
-47.0%
91,367
-48.0%
0.45%
-74.1%
Q3 2020$3,136,000
-19.3%
175,799
-18.9%
1.75%
+11.8%
Q2 2020$3,887,000
+18.1%
216,7660.0%1.57%
+84.0%
Q1 2020$3,291,000
-8.1%
216,766
+19.3%
0.85%
-26.0%
Q4 2019$3,583,000
+63.0%
181,625
+42.1%
1.15%
+45.8%
Q3 2019$2,198,000
-2.8%
127,7710.0%0.79%
-33.4%
Q2 2019$2,262,000
-14.2%
127,771
-1.2%
1.19%
-34.5%
Q1 2019$2,635,000129,3711.81%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders